淋巴瘤和白血病细胞的脆弱性和抵抗性通过复合图书馆屏幕识别
Katarzyna Tomska1,2, Sebastian Scheinost3, Jarno Kivioja4
1Department of Molecular Therapy in Hematology and Oncology, DKFZ & NCT Heidelberg, Heidelberg, Germany.
Methods in molecular biology (Clifton, N.J.)
|October 18, 2024
概括
鉴定抗癌药物反应的生物标志物对于个性化医学至关重要. 这项研究提出了一种可扩展的基于ATP的活力测试,以了解细胞系和初级细胞中的药物反应,帮助发现生物标志物.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物标志物发现发现
背景情况:
- 患者对抗癌药物的反应有很大差异,需要确定预测性生物标志物.
- 了解药物反应异质性是提高癌症治疗疗效的关键.
- 高通量查平台对于识别生物标志物和阐明药物反应机制至关重要.
研究的目的:
- 提出一种简单,可扩展的方法来测量药物暴露后的细胞活力.
- 利用这种方法了解细胞系和原始细胞中的药物反应.
- 促进与可变药物反应相关的生物标志物的发现.
主要方法:
- 采用腺三酸盐 (ATP) 测量作为细胞活力的替代品.
- 应用高通量查方法来评估药物反应.
- 利用癌症细胞系和初级细胞的短期培养.
主要成果:
- 展示了一种可扩展的方法来量化药物诱导的细胞活力的变化.
- 为各种化合物对细胞反应的全面绘制提供了一个框架.
- 能够研究跨多种癌症模型的药物反应,包括来自患者的样本.
结论:
- 开发的基于ATP的活力测定是评估药物反应的宝贵工具.
- 该方法支持识别生物标志物和对治疗变异性的机制性见解.
- 提高了个性化抗癌药物选择和改善治疗结果的潜力.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K